Anthony Petrone's questions to Resmed Inc (RMD) leadership • Q2 2025
Question
Anthony Petrone from Mizuho Group asked about the future reimbursement landscape for GLP-1s and CPAP, specifically whether commercial payers might eventually require patients to try CPAP first before covering a GLP-1 for sleep apnea.
Answer
Executive Michael Farrell stated that while private payers often follow Medicare, the situation is complex as GLP-1s target broad obesity, not just sleep apnea. He highlighted that Eli Lilly's own data and educational materials follow AASM guidelines, positioning PAP therapy as the frontline gold standard. He believes the data supports combination therapy as the most effective approach, which should influence payer decisions and physician behavior as consumer advertising for GLP-1s increases.